Cargando…
Prolyl 4-Hydroxylase Domain Protein 3-Inhibited Smooth-Muscle-Cell Dedifferentiation Improves Cardiac Perivascular Fibrosis Induced by Obstructive Sleep Apnea
BACKGROUND: Intermittent hypoxia (IH) induced by obstructive sleep apnea (OSA) is a leading factor affecting cardiovascular fibrosis. Under IH condition, smooth muscle cells (SMAs) respond by dedifferentiation, which is associated with vascular remodelling. The expression of prolyl 4-hydroxylase dom...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6621170/ https://www.ncbi.nlm.nih.gov/pubmed/31346526 http://dx.doi.org/10.1155/2019/9174218 |
_version_ | 1783434117111611392 |
---|---|
author | Tong, Jiayi Yu, Fu-chao Li, Yang Wei, Qin Li, Chen Zhen, Penghao Zhang, Guanghao |
author_facet | Tong, Jiayi Yu, Fu-chao Li, Yang Wei, Qin Li, Chen Zhen, Penghao Zhang, Guanghao |
author_sort | Tong, Jiayi |
collection | PubMed |
description | BACKGROUND: Intermittent hypoxia (IH) induced by obstructive sleep apnea (OSA) is a leading factor affecting cardiovascular fibrosis. Under IH condition, smooth muscle cells (SMAs) respond by dedifferentiation, which is associated with vascular remodelling. The expression of prolyl 4-hydroxylase domain protein 3 (PHD3) increases under hypoxia. However, the role of PHD3 in OSA-induced SMA dedifferentiation and cardiovascular fibrosis remains uncertain. METHODS: We explored the mechanism of cardiovascular remodelling in C57BL/6 mice exposed to IH for 3 months and investigated the mechanism of PHD3 in improving the remodelling in vivo and vitro. RESULTS: In vivo remodelling showed that IH induced cardiovascular fibrosis via SMC dedifferentiation and that fibrosis improved when PHD3 was overexpressed. In vitro remodelling showed that IH induced SMA dedifferentiation, which secretes much collagen I. PHD3 overexpression in cultured SMCs reversed the dedifferentiation by degrading and inactivating HIF-1α. CONCLUSION: OSA-induced cardiovascular fibrosis was associated with SMC dedifferentiation, and PHD3 overexpression may benefit its prevention by reversing the dedifferentiation. Therefore, PHD3 overexpression has therapeutic potential in disease treatment. |
format | Online Article Text |
id | pubmed-6621170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-66211702019-07-25 Prolyl 4-Hydroxylase Domain Protein 3-Inhibited Smooth-Muscle-Cell Dedifferentiation Improves Cardiac Perivascular Fibrosis Induced by Obstructive Sleep Apnea Tong, Jiayi Yu, Fu-chao Li, Yang Wei, Qin Li, Chen Zhen, Penghao Zhang, Guanghao Biomed Res Int Research Article BACKGROUND: Intermittent hypoxia (IH) induced by obstructive sleep apnea (OSA) is a leading factor affecting cardiovascular fibrosis. Under IH condition, smooth muscle cells (SMAs) respond by dedifferentiation, which is associated with vascular remodelling. The expression of prolyl 4-hydroxylase domain protein 3 (PHD3) increases under hypoxia. However, the role of PHD3 in OSA-induced SMA dedifferentiation and cardiovascular fibrosis remains uncertain. METHODS: We explored the mechanism of cardiovascular remodelling in C57BL/6 mice exposed to IH for 3 months and investigated the mechanism of PHD3 in improving the remodelling in vivo and vitro. RESULTS: In vivo remodelling showed that IH induced cardiovascular fibrosis via SMC dedifferentiation and that fibrosis improved when PHD3 was overexpressed. In vitro remodelling showed that IH induced SMA dedifferentiation, which secretes much collagen I. PHD3 overexpression in cultured SMCs reversed the dedifferentiation by degrading and inactivating HIF-1α. CONCLUSION: OSA-induced cardiovascular fibrosis was associated with SMC dedifferentiation, and PHD3 overexpression may benefit its prevention by reversing the dedifferentiation. Therefore, PHD3 overexpression has therapeutic potential in disease treatment. Hindawi 2019-06-27 /pmc/articles/PMC6621170/ /pubmed/31346526 http://dx.doi.org/10.1155/2019/9174218 Text en Copyright © 2019 Jiayi Tong et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Tong, Jiayi Yu, Fu-chao Li, Yang Wei, Qin Li, Chen Zhen, Penghao Zhang, Guanghao Prolyl 4-Hydroxylase Domain Protein 3-Inhibited Smooth-Muscle-Cell Dedifferentiation Improves Cardiac Perivascular Fibrosis Induced by Obstructive Sleep Apnea |
title | Prolyl 4-Hydroxylase Domain Protein 3-Inhibited Smooth-Muscle-Cell Dedifferentiation Improves Cardiac Perivascular Fibrosis Induced by Obstructive Sleep Apnea |
title_full | Prolyl 4-Hydroxylase Domain Protein 3-Inhibited Smooth-Muscle-Cell Dedifferentiation Improves Cardiac Perivascular Fibrosis Induced by Obstructive Sleep Apnea |
title_fullStr | Prolyl 4-Hydroxylase Domain Protein 3-Inhibited Smooth-Muscle-Cell Dedifferentiation Improves Cardiac Perivascular Fibrosis Induced by Obstructive Sleep Apnea |
title_full_unstemmed | Prolyl 4-Hydroxylase Domain Protein 3-Inhibited Smooth-Muscle-Cell Dedifferentiation Improves Cardiac Perivascular Fibrosis Induced by Obstructive Sleep Apnea |
title_short | Prolyl 4-Hydroxylase Domain Protein 3-Inhibited Smooth-Muscle-Cell Dedifferentiation Improves Cardiac Perivascular Fibrosis Induced by Obstructive Sleep Apnea |
title_sort | prolyl 4-hydroxylase domain protein 3-inhibited smooth-muscle-cell dedifferentiation improves cardiac perivascular fibrosis induced by obstructive sleep apnea |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6621170/ https://www.ncbi.nlm.nih.gov/pubmed/31346526 http://dx.doi.org/10.1155/2019/9174218 |
work_keys_str_mv | AT tongjiayi prolyl4hydroxylasedomainprotein3inhibitedsmoothmusclecelldedifferentiationimprovescardiacperivascularfibrosisinducedbyobstructivesleepapnea AT yufuchao prolyl4hydroxylasedomainprotein3inhibitedsmoothmusclecelldedifferentiationimprovescardiacperivascularfibrosisinducedbyobstructivesleepapnea AT liyang prolyl4hydroxylasedomainprotein3inhibitedsmoothmusclecelldedifferentiationimprovescardiacperivascularfibrosisinducedbyobstructivesleepapnea AT weiqin prolyl4hydroxylasedomainprotein3inhibitedsmoothmusclecelldedifferentiationimprovescardiacperivascularfibrosisinducedbyobstructivesleepapnea AT lichen prolyl4hydroxylasedomainprotein3inhibitedsmoothmusclecelldedifferentiationimprovescardiacperivascularfibrosisinducedbyobstructivesleepapnea AT zhenpenghao prolyl4hydroxylasedomainprotein3inhibitedsmoothmusclecelldedifferentiationimprovescardiacperivascularfibrosisinducedbyobstructivesleepapnea AT zhangguanghao prolyl4hydroxylasedomainprotein3inhibitedsmoothmusclecelldedifferentiationimprovescardiacperivascularfibrosisinducedbyobstructivesleepapnea |